Background: Transpupillary thermotherapy is a new and most promising treatment modality for up to medium-sized choroidal melanoma at the posterior pole. We analysed the results of conventional ruthenium-106 brachytherapy in these special tumour subgroup.

Patients And Methods: Results of ruthenium-106 brachytherapy (radioactive dose to the tumour apex 150 Gy) in a series of 52 eyes with primary malignant choroidal melanoma (posterior to the equator, thickness
Results: Tumour control was achieved in 48 eyes (92 %): completely flattened scar in 71 %, residual prominence
Conclusion: In posterior choroidal melanoma ruthenium-brachytherapy achieved an excellent rate of tumour control, but functional results were disappointing because of late radiation sideeffects. Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy may be able to reduce the radioactive dose.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2002-30654DOI Listing

Publication Analysis

Top Keywords

ruthenium-106 brachytherapy
12
melanoma posterior
12
choroidal melanoma
8
[retrospective analysis
4
analysis ruthenium-106
4
brachytherapy small
4
small medium-sized
4
medium-sized malignant
4
malignant melanoma
4
posterior choroid]
4

Similar Publications

Clinical Features and Initial Management Outcomes of Uveal Melanomas in a Single Tertiary Center in Egypt.

Ocul Oncol Pathol

December 2024

Cairo University Ocular Oncology Service, Department of Ophthalmology, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.

Article Synopsis
  • The study focuses on the demographic, clinical, and management outcomes of patients with uveal melanoma at a tertiary center in Egypt over five years.
  • A total of 93 patients were treated, with most tumors being choroidal, and common treatments included brachytherapy and gamma knife radiosurgery, leading to a successful globe salvage rate of 84.62%.
  • The conclusion emphasizes the importance of timely referrals and proper assessments to improve treatment success and highlights the need for advanced tumor patients to consider enucleation to lower the risk of metastasis and mortality.
View Article and Find Full Text PDF

Expert Opinions on Uveal Melanoma: Insights from the 58th Ophthalmic Oncology Group Meeting.

Ocul Oncol Pathol

December 2024

Ophthalmology Department, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.

Introduction: Clear evidence for the best clinical management of uveal melanoma is lacking in some areas. Therefore, reports on expert opinions in the field can be valuable.

Methods: A questionnaire comprising 10 questions was distributed to potential participants of the 58th Ophthalmic Oncology Group Meeting in Stockholm, Sweden, in June 2024.

View Article and Find Full Text PDF

Purpose: To describe the clinical presentation and treatment outcomes of patients undergoing Ruthenium-106 (Ru) plaque brachytherapy as salvage treatment for retinoblastoma (RB) following intravenous chemotherapy (IVC).

Methods: Retrospective chart review of 44 eyes of 42 patients. The indications for plaque brachytherapy included solid tumor recurrence (n=20; 45%), solid tumor residual (n=16; 36%), new subretinal seeds (n=5; 12%), and new solid tumor (n=3; 7%).

View Article and Find Full Text PDF

Plaque Radiotherapy for Ocular Melanoma.

Cancers (Basel)

October 2024

Department of Ophthalmology, National University Health System, Singapore 119228, Singapore.

Article Synopsis
  • Plaque radiotherapy is a targeted treatment for medium-sized ocular tumors like uveal melanoma, using customized plaques to deliver precise radiation while minimizing damage to surrounding healthy tissue.
  • The choice of radioisotope, such as Ruthenium-106 or Iodine-125, is based on factors like tumor characteristics and desired treatment duration, with high dose rate (HDR) options facilitating quicker treatment.
  • Efficacy of Ruthenium-106 varies significantly, and outcomes can be influenced by tumor size, thickness, and location; however, plaque brachytherapy can offer similar survival rates to more invasive treatments like enucleation for suitable cases.
View Article and Find Full Text PDF

Ruthenium-106 Plaque Brachytherapy for Circumscribed Choroidal Hemangioma: A Case Series and Review of Literature.

Ocul Oncol Pathol

September 2024

Cairo University Ocular Oncology Service, Department of Ophthalmology, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt.

Article Synopsis
  • * Conducted at Cairo University, it included a retrospective analysis of 7 male patients, with a significant mean age of 39.3 years, all of whom showed marked improvement in vision and tumor size after treatment.
  • * Results indicated that the therapy not only reduced tumor dimensions and resolved associated complications, but also highlighted a positive safety profile, with no recurrences or significant radiation-related issues reported during a follow-up period of about 12.5 months.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!